UNSPSC 51283724: Cefuroxime axetil

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z49QDT0J8Z. European Medicines Agency schedules Cefuroxime axetil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01139MIG. Cefuroxime axetil generally arises in the molecular formula C20H22N4O10S. The term 'cefuroxime axetil' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule cefuroxime axetil under HS 29419000 and SITC 54139.

As of Q4 2014, CEFUROXIME AXETIL remains US FDA's Preferred Term for this commodity. Cefuroxime axetil bears US NLM identifiers UMLS ID C0055015 and NCI Concept Code C28918. SMILES: CC(OC(=O)C)OC(=O)C1=C(CS[C@H]2N1C(=O)[C@H]2NC(=O)/C(=N\OC)/C3CCCO3)COC(=O)N.

UNSPSC 51283724 Cefuroxime axetil is a Commodity code for a specific oral antibiotic pharmaceutical product, but recent state and local contract opportunities show minimal activity aligned with this code's narrow scope. The two most recent opportunities tagged to this code involve unrelated pharmaceutical categories — one covering antibiotic tablets (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) procured through a consortium piggyback vehicle, and another covering Naloxone and drug deactivation systems for community health support. Neither solicitation targets cefuroxime axetil specifically, indicating either inconsistent tagging in the source system or a mismatch between the code assignment and actual procurement content.

State and local government procurement under this code shows limited documented activity. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC (completed August 28, 2026), and Seminole County, Florida released an IFB for Naloxone and drug deactivation systems with a response deadline of July 26, 2023. Both opportunities involve state health departments or county health authorities as the primary issuing bodies. Geographic activity appears concentrated in Florida and Illinois based on recent records, though the lack of cefuroxime-specific solicitations suggests this Commodity code sees minimal targeted procurement volume in the current state and local market. Vendors pursuing this code should verify that actual opportunities align with cefuroxime axetil supply before investing in proposal development.